According to Diabetes Daily, a recent survey by Thrivable, a diabetes market research firm, demonstrated that people with type 1 diabetes who use GLP-1 drugs are far more likely to think positively about the future of diabetes treatment: 41.2 percent of GLP-1 users reported feeling optimistic, compared with a mere 5.6 percent of nonusers
I had tendonitis in my elbow, I started using BPC-157 and it was gone in two weeks, Rogan told his podcast audience last year
Studies comparing combination therapy to individual peptides in muscle injury models show enhanced recovery outcomes including faster restoration of contractile function, reduced fibrosis, and improved tissue architecture
Decisions about GLP-1 medications should always be made with your own doctor
Biochimica et Biophysica Acta, Molecular Basis of Disease